Extending neurotransmitter hypotheses of neuroleptic action and schizophrenia beyond cell-surface receptors. The phosphoinositide signalling system provides a link between receptors and intracellular calcium

Abdel-Latif A.A. (1986) Calcium-mobilizing receptors, polyphosphoinositides, and the generation of second messengers. Pharmacol Rev 38: 227-277

Allison J.G. , Stewart M.A. (1971) Reduced brain inositol in lithium-treated rats . Nature 233: 267-268

Allison J.H. , Blisner M.E. , Holland W.H. , Hippius P.P. , Sherman W.R. (1976) Increased brain myo-inositol-1-phosphate in lithium-treated rats. Biochem Biophys Res Commun 71: 664-670

Baastrup P.C. , Poulsen J.C. , Schou M. , Thomsen K. , Amdisen A. (1970) Prophylactic lithium: double-blind discontinuation in manic depressive and recurrent depressive disorders. Lancet ii: 326-330

Baldessarini R.J. (1980) Drugs and the treatment of psychiatric disorders . In Gilman A G , Goodman L S , Gilman A (eds), Goodman and Gilman's the pharmacological basis of therapeutics. Macmillan, New York, pp. 391-418

Barany M. , Arus C. , Chang Y.C. (1985) Natural abundance 13C-NMR of brain. Magnet Reson Med 2: 289-295

Baraban J.M. , Worley P.F. , Snyder S.H. (1989) Second messenger systems and psychoactive drug action: focus on the phospoinositide system and lithium. Am J Psychiatr 146: 1251-1260

Berridge M.J. , Irvine R.F. (1989) Inositol phosphates and cell signalling. Nature 341: 197-205

Berridge M.J. , Downes C.P. , Hanley M.R. (1982) Lithium amplifies agonist-dependent phosphoinositide responses in brain and salivary glands. Biochem J 206: 587-595

Biederman J. , Lernar Y. , Belmaker R.H. (1979) Combination of lithium carbonate and haloperidol in schizoaffective disorder: a controlled study. Arch Gen Psychiatr 36: 327-333

Braden W. , Fink E.B. , Qualls C.B. , Ho C.H. , Samuels W.O. (1982) Lithium and chlorpromazine in psychotic inpatients . Psychiatr Res 7: 69-81

Bradley P.B. (1986) Pharmacology of antipsychotic drugs. In Bradley P B , H irsch S R (eds), The psychopharmacology and treatment of schizophrenia. Oxford University Press, Oxford New York Tokyo, pp. 27-70

Branchey M.H. , Charles J. , Simpson G.M. (1976) Extrapyramidal side effects in lithium maintenance therapy. Am J Psychiatr 133: 444-445

Campbell I.C. , McWilliam J.R. , Adamson P. (1987) Central adrenergic receptors. J Psychopharmacol 2: 55-66

Canonico P.L. , Valdenegro C.A. , MacLeod R.M. (1983) The inhibition of phosphatidylinositol turnover: a possible post-receptor mechanism for the prolactin secretion-inhibiting effect of dopamine. Endocrinology 113: 7-13

Canonico P.L. , Jarvis W.D. , Judd A.M. , MacLeod R.M. (1986) Dopamine does not attenuate phosphoinositide hydrolysis in rat anterior pituitary cells. J Endocrinol 110: 389-393

Carlsson A. (1978) Antipsychotic drugs, neurotransmitters and schizophrenia . Am J Psychiatr 135: 164-173

Carlsson A. , Lindqvist M. (1963) Effect of chlorpromazine and haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol 20: 140-143

Carman J.S. , Bigelow L.B. , Wyatt R.H. (1981) Lithium combined with neuroleptics in chronic schizophrenic and schizoaffective patients. J Clin Psychiatr 42: 124-128

Cohen W.J. , Cohen N.H. (1974) Lithium carbonate, haloperidol and irreversible brain damage. J Am Med Assoc 230: 1283-1287

Cohen M.M. , Pettegrew J.W. , Kopp S.J. , Minshew N. , Glonek T. (1984) 31P nuclear magnetic resonance analysis of brain: normoxic and anoxic brain slices. Neurochem Res 9: 785-801

Connell P.H. (1958) Amphetamine psychosis. Maudsley Monograph No. 5. Chapman and Hall, London

Creese I. , Burt D.R. , Snyder S.H. (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192: 481-483

Creese I. , Sibley DR , Hamblin M.W. , Leff S.E. (1983) The classification of dopamine receptors: relationship to radioligand binding. Annu Rev Neurosci 6: 43-71

Crow T.J. , Johnstone E.C. , Longden A. , Owen F. ( 1976) Dopaminergic mechanisms in schizophrenia: The antipsychotic effect and the disease process. Life Sci 23: 563-568

Dawson V.L. , Dawson T.M. , Filloux F.M. , Wamsley J.K. (1988) Evidence for dopamine D-2 receptor on cholinergic interneurons in the rat caudate-putamen. Life Sci 42: 1933-1939

Delva N.J. , Letemendia F J J (1982) Lithium treatment in schizophrenia and schizoaffective disorders. Br J Psychiatr 141: 387-400

Donaldson S.R. , Gelenberg A.J. , Baldessarini R.J. (1983) The pharmacologic treatment of schizophrenia: a progress report. Schizophrenia Bull 9: 504-527

Ebstein R.P. , Newman M.E. , Bunnett E.R. , Lerer B. (1989) Mechanism of lithium and ECT action in affective disorder: modulation of post-receptor second messenger function. In Tipton K F , Youdium M B H (eds) Biochemical and pharmacological aspects of depression . Taylor & Francis, London , pp. 123-141

Enjalbert A. , Sladeczek F. , Guillon G. , Bertrand P. , Shu C. , Epelbaum J. , Garcia-Sainz A. , Jard S. , Lombard C. , Kordon C. , Bockaert J. (1986) Angiotensin II and dopamine modulate both cAMP and inositol phosphate production in anterior pituitary cells. Involvement in prolactin secretion. J Biol Chem 26: 4071-4075

Enjalbert A. , Guillon G. , Mouillac B. , Audinot V. , Rasolonjanhary R. , Kordon C. , Bockaert J. (1990) Dual mechanisms of inhibition by dopamine of basal and thyrotropin-releasing hormone-stimulated inositol phosphate production in anterior pituitary cells. J Biol Chem 265: 18816-18822

Erecinska M. , Silver I.S. (1989) ATP and brain function. J Cerebral Blood Flow Metab 9: 2-19

Essali M.A. , Das I. , de Belleroche J. , Hirsch S.R. (1990) The platelet polyphosphoinositide system in schizophrenia: the effect of neuroleptic treatment. Biol Psychiatr 28: 475-487

Essali M.A. , Das I. , de Belleroche J. , Hirsch S.R. (1991) Neuroleptics, lithium, inositol phosphates and calcium: A novel approach to the pharmacology of psychosis. In Reid E , Cook G M W , Luzio J P (eds), Methodological surveys in biochemistry and analysis, Volume 21. Cell signalling: experimental strategies. The Royal Society of Chemistry, London, pp. 185-188

Essali M.A. , Das I. , de Belleroche J. , Hirsch S.R. (1992) Calcium mobilization in platelets from schizophrenic and healthy subjects. Regulation by lithium and neuroleptics. J Psychopharmacol 6: 389-394

Euvrard C. , Premont J. , Oberlander C. , Boissies J.R. , Bockaert J. (1979) Is dopamine-sensitive adenylate cyclase involved in regulating the activity of striatal cholinergic neurons? Naunyn-Schmiedeberg's Arch Pharmacol 309: 241-245

Fisher S.K. , Bartus R.T. (1985) Regional differences in the coupling of muscarinic receptors to inositol phospholipid hydrolysis in guinea pig brain. J Neurochem 45: 1085-1095

Fujiwara H. , Kato N. , Shuntoh H. , Tanaka C. (1987) D2 dopamine receptor-mediated inhibition of intracellular Ca2+ mobilization and release of acetylcholine from guinea-pig neo-striatal slices. Br J Pharmacol 91: 287-297

Gershengorn M.C. (1986) Mechanism of thyrotropin releasing hormone stimulation of pituitary hormone secretion. Annu Rev Physiol 48: 515-526

Glonek T. , Kopp S.J. , Kot E. , Pettegrew J.W. , Harrison W.H. , Cohen M.M. (1982) 31P nuclear magnetic resonance analysis of brain: The perchloric acid extract spectrum. J Neurochem 39: 1210-1219

Haase H.J. , Janssen P A J (1985) The action of neuroleptic drugs, 2nd edition. Elsevier, Amsterdam, New York and Oxford , pp. 287-317

Hartigan C.P. (1963). The use of lithium salt in affective disorders . Br J Psychiatr 109: 810-814

Himmelhoch J.M. , Neil J.F. (1980) Lithium therapy in combination with other forms of treatment. In Johnson F N (ed.), Handbook of lithium therapy. MTP Press, London, pp. 51-67

Hirsch S.R. (1986) Clinical treatment of schizophrenia. In Bradley P B , Hirsch S R (eds), The Psychopharmacology and treatment of schizophrenia. Oxford University Press, Oxford, pp. 286-339

Hokin L.E. (1985) Receptor and phosphoinositide-generated second messengers. Annu Rev Biochem 54: 205-235

Iversen L.L. , Reynolds G.P. , Snyder S.H. (1983) Pathophysiology of schizophrenia—causal role for dopamine or noradrenaline? Nature 305: 577-578

Jarvis W.D. , Judd A.M. , MacLeod (1988) Attenuation of anterior pituitary phosphoinositide phosphorylase activity by the D2 dopamine receptor. Endocrinology 123: 2793-2799

Kelly E. , Batty I. , Nahorski S.R. (1988) Dopamine receptor stimulation does not affect phosphoinositide hydrolysis in slices of rat striatum. J Neurochem 51: 918-924

Keshavan M.S. , Pettegrew J.W. , Panchalingam K. , Kaplan D. , Brar J. ( 1989) In vivo 31P nuclear magnetic resonance (NMR) spectroscopy of the frontal lobe metabolism in neuroleptic naive first episode psychoses: preliminary studies. Schizophrenia Res 2: 122

Komulainen H. , Bondy C. (1988) Increased free intracellular Ca2+ by toxic agents: an index of potential neurotoxicity? Trends Pharmacol Sci 9: 154-156

Lehmann J. , Langer S.Z. (1983) The striatal cholinergic interneurons: synaptic target of dopaminergic terminals? Neuroscience 10: 1105-1120

Leong D.A. , Frawley L.S. , Neill J.D. (1983) Neuroendocrine control of prolactin secretion. Annu Rev Physiol 45: 109-127

Loudon J.B. , Waring H. (1976) Toxic reactions to lithium and haloperidol. Lancet i: 1088

Mann S.C. , Greenstein R.A. , Eilers R. (1983) Early onset of severe dyskinesia following lithium-haloperidol treatment. Am J Psychiatr 140: 1385-1386

Manayam N.V. , Bravo-Fernandez E. (1973) Lithium carbonate in Huntington chorea. Lancet i: 1010

Marinier D.S. , Letoublon R. , Delmau J. (1988) Phosphorus NMR analysis of human white matter in mixed non-ionic detergent micelles. J Lipid Res 29: 1237-1243

Martin J.B. , Foray M.F. , Klein G. , Satre M. (1987) Identification of inositol hexaphosphate in 31P NMR spectra of Dictyostelium discoideum amoebae. Relevance to intracellular pH determination. Biochim Biophys Acta 931: 16-25

Martin T F J , Lucas D.O. , Bajjaieh S.M. , Kowalchyk J.A. (1986) Thyrotropin-releasing hormone activates a Ca2+-dependent phosphoinositide phosphodiesterase in permeable GH3 cells. J Biol Chem 261: 2918-2927

Martinez de la Escalera G. , Weiner R.I. (1988a) Mechanisms by which the transient removal of DA regulation potentiates the PRL releasing action of TRH. Neuroendocrinology 47: 186-193

Martinez de la Escalera G.M. , Weiner R.I. (1988b) Effect of dopamine withdrawal on activation of adenylate cyclase and phospholipase C in enriched lactotrophs. Endocrinology 123: 1682-1687

Martinez de la Escalera G. , Martin T F J , Weiner R.I. (1987) Phosphoinositide hydrolysis in response to the withdrawal of DA inhibition in enriched lactotrophs in culture. Neuroendocrinology 46: 545-548

Martinez de la Escalera G. , Porter B.W. , Martin T F J , Weiner R.I. (1989) Dopamine withdrawal and addition of thyrotropin-releasing hormone stimulates membrane translocation of protein kinase-C and phosphorylation of an endogenous 80 K substrate in enriched lactotrophs. Endocrinology 125: 1168-1173

Mattsson B. (1973) Huntington's chorea and lithium therapy. Lancet i: 718-719

Mayr GW , Dietrich W. (1987) The only inositol tetrakisphosphate detectable in avian erythrocyte is the isomer lacking phosphate at position 3: a NMR study. FEBS Lett 213: 278-282

Meltzer H.Y. (1980) Relevance of dopamine autoreceptors for psychiatry: Preclinical and clinical studies. Schizophrenia Bull 6: 456-475

Memo M. , Castelletti L. , Missale C. , Valerio A. , Carruba M. , Spano P.F. (1986a) Dopaminergic inhibition of prolactin release and calcium influx induced by neurotensin in anterior pituitary is independent of cyclic AMP system. J Neurochem 47: 1689-1695

Memo M. , Missale C. , Carruba M.O. , Spano P.F. (1986b) D-2-dopamine receptors associated with inhibition of dopamine release from rat neostriatum are independent of cyclic AMP. Neurosci Lett 71: 192-196

Michell R.H. (1986) Inositol lipids and their role in receptor function: history and general principles. In Putney J W Jr (ed.), Phosphoinositide and receptor mechanisms. Alan R. Liss Inc. pp. 1-24

Morra M. , Leboulenger F. , Desrues L. , Tonon M.C. , Vaudry H. (1991) Dopamine inhibits inositol phosphate production, arachidonic acid formation, and corticosteroid release by frog adrenal gland through a pertussis toxin-sensitive G-protein. Endocrinology 128: 2625-2632

Nahorski R.N. , Kendall D.A. , Batty I. (1986) Receptors and phospoinositide metabolism in the central nervous system. Biochem Pharmacol 35: 2447-2453

Nahorski S.R. , Ragan C.I. , Challiss R A J (1991) Lithium and the phosphoinositide cycle: an example of uncompetitive inhibition and its pharmacological consequences. Trends Pharmacol Sci 12: 297-303

Peroutka S.J. , U'Prichard D. , Greenberg D.A. (1977) Neuroleptic drugs interactions with epinephrine alpha receptor binding sites in rat brain. Neuropharmacology 16: 549-556

Petit A. , Guillon G. , Pantalon C. , Tence M. , Gallo-Payet N. , Ballabarba D. , Lehoux J.G. , Belisle S. (1990) An islet-activating protein-sensitive G-protein is involved in dopamine inhibition of both angiotensin-stimulated inositol phosphate production and human placental lactogen release in human trophoplastic cells. J Clin Endocrinol Metab 17: 1573-1580

Petroff O.A. , Hogan E. , Johansen J. , Kleinhaus A.L. (1987) Proton magnetic resonance spectroscopy of leech muscle and nervous system. Comp Biochem Physiol 87: 927-931

Pettegrew J.W. , Kopp S.J. , Minshew N.J. , Glonek T. , Feliksik J.M. , Tow J.P. , Cohen M.M. (1987) 31p Nuclear magnetic resonance studies of phosphoglyceride metabolism in developing and degenerating brain: preliminary observations . J Neuropathol Exp Neurol 46: 419-430

Pizzi M. , D'Agostini F. , Da Prada M. , Spano P.F. , Haefely W.E. (1987) Dopamine D-2 receptor stimulation decreases the inositol triphosphate level of rat striatal slices. Eur J Pharmacol 136: 263-264

Pizzi M. , Da Prada M. , Valerio A. , Memo M. Spano P.F. , Haefely W.E. (1988) Dopamine D2 receptor stimulation inhibits inositol phosphate generating system in rat striatal slices. Brain Res 456: 235-240

Putney J.W. (1986) A model for receptor-regulated calcium entry. Cell Calcium 7: 1-12

Randrup A. , Munkvad I. (1967) Stereotyped activities produced by amphetamine in several animal species and man. Psychopharmacologia 11: 300-310

Rasmussen H. (1986) The calcium messenger system. New Engl J Med 314: 1094-1101, 1164-1170

Rasmussen H. , Barret PQ (1984) Calcium messenger system: an integrated view. Physiol Rev 64: 938-984

Reches A. , Wagner H.R. , Jackson V. , Fahn S. ( 1982) Chronic lithium treatment has no effect on haloperidol supersensitivity of pre- and postsynaptic dopamine receptors in rat brain . Brain Res 246: 172-177

Reed L. , de Belleroche J. (1988) Increased polyphosphoinositide responsiveness in the cerebral cortex induced by cholinergic denervation. J Neurochem 50: 1566-1571

Renshaw P.F. , Schnall M.D. , Leigh J.S. Jr (1987) In vivo 31 P NMR spectroscopy of agonist-stimulated phosphatidylinositol metabolism in cat brain. Magnet Reson Med 4: 221-226

Rosenblatt J.E. , Pert A. , Layton B. , Bunney W.E. Jr (1980) Chronic lithium reduces [3H ] spiroperidol binding in rat striatum. Eur J Pharmacol 67: 321-322

Schenk G. , Leijnse-Ybema H.J. (1974) Huntington's chorea and levodopa. Lancet i: 364

Schofield T.G. (1983) Use of trapped fluorescent indicator to demonstrate effects of thyroliberin and dopamine on cytoplasmic calcium concentrations in bovine anterior pituitary cells. FEBS Lett 150: 79-82

Schrey M.P. , Clark H.J. , Franks S. (1986) The dopaminergic regulation of anterior 45 Ca2+ homeostasis and prolactin secretion. J Endocrinol 108: 423-429

Seeman P. (1987) Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1: 133-152

Seeman P. , Lee T. , Chau-Wong M. , Wong K. ( 1976) Antipsychotic drug doses and neuroleptic/dopamine receptors . Nature 261: 717-719

Sherman W.H. (1989) Inositol homeostasis, lithium and diabetes. In Michell R H , Drummond A H , Downes C P (eds), Inositol lipids in cell signalling. Academic Press , London, pp. 39-79

Simmonds S.H. , Strange P.G. (1985) Inhibition of inositol phospholipid breakdown by D-2 dopamine receptors in dissociated bovine anterior pituitary cells. Neurosci Lett 60: 267-272

Small J.G. , Kellans J.J. , Milstein V. , Moore J. (1975) A placebo-controlled study of lithium combined with neuroleptics in chronic schizophrenic patients. Am J Psychiatr 132: 1315-1317

Snyder S.H. (1984) Drugs and neurotransmitter receptors in the brain . Science 224: 22-31

Snyder S.H. , Greenberg D. , Yamamura H.I. (1974) Antischizophrenic drugs and the brain cholinergic receptors. Arch Gen Psychiatr 31: 58-61

Stoof J.C. , Kebabian J.W. (1982) Independent in vitro regulation by the D2 dopamine receptor of dopamine-stimulated efflux of cyclic AMP and K+-stimulated release of acetylcholine from rat neostriatum. Brain Res 250: 263-270

Stoof J.C. , Kebabian J.W. (1984) Two dopamine receptors: biochemistry, physiology and pharmacology. Life Sci 35: 2281-2296

Stoof J.C. , Verheijden P F H M , Leysen J.E. (1987) Stimulation of D-2 receptors in rat nucleus accumbens slices inhibits dopamine and acetylcholine release but not cyclic AMP formation . Brain Res 423: 364-368

Szwerrgold B.S. , Graham R.A. , Brown T.R. (1987) Observation of inositol pentakis- and hexakis-phosphates in mammalian tissues by 31P NMR. Biochem Biophys Res Commun 149: 874-881

Tuomisto J. , Mannisto P. (1985) Neurotransmitter regulation of anterior pituitary hormones. Pharmacol Rev 37: 249-332 Vallar L. , Vicentini L.M. , Meldolesi J. (1988) Inhibition of inositol phosphate production is a late, Ca2+-dependent effect of D2 dopaminergic receptor activation in rat lactotroph cells. J Biol Chem 263: 10127-10134

Van Rooijen L A A , Dompert W.U. , Horvath E. , Spencer D.G. Jr, Traber J. (1986) Pharmacological aspects of the inositide response in the central nervous system: the muscarinic acetylcholine receptor. In Gipson W H , Routtenberg A (eds), Progress in brain research vol. 69. pp. 65-74

van Rossum JM (1966) The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs. Arch Int Pharmacodyn Ther 160: 492-494

Weller M P I (1983) Neuroleptics. In Weller M (ed.), The scientific basis of psychiatry. Bailliere Tindall, London, pp.225-238